NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 133 filers reported holding NOVAVAX INC in Q1 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $696,000 | -64.0% | 1,265,723 | +20.3% | 0.00% | -100.0% |
| Q4 2018 | $1,936,000 | +1273.0% | 1,052,214 | +1303.0% | 0.00% | – |
| Q3 2018 | $141,000 | +39.6% | 75,000 | 0.0% | 0.00% | – |
| Q2 2018 | $101,000 | +90.6% | 75,000 | +74.6% | 0.00% | – |
| Q4 2017 | $53,000 | -15.9% | 42,966 | -14.1% | 0.00% | – |
| Q4 2016 | $63,000 | -42.2% | 50,000 | -4.4% | 0.00% | – |
| Q3 2016 | $109,000 | -70.1% | 52,300 | +4.6% | 0.00% | -100.0% |
| Q2 2016 | $364,000 | +41.1% | 50,000 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $258,000 | -60.4% | 50,000 | -35.5% | 0.00% | 0.0% |
| Q4 2015 | $651,000 | +358.5% | 77,500 | +287.5% | 0.00% | – |
| Q3 2015 | $142,000 | -92.4% | 20,000 | -93.6% | 0.00% | -100.0% |
| Q4 2014 | $1,863,000 | +23.1% | 314,171 | -13.4% | 0.01% | +20.0% |
| Q3 2014 | $1,513,000 | – | 362,920 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |